Celldex reports sustained angioedema improvements 7 months post-treatment
Go back to Celldex reports sustained angioedema improvements 7 months post-treatment| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 33.64 +0.23 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.41 | 52 Week High | $18.62 | |||
| Open | $32.87 | 52 Week Low | $2.85 | |||
| Day High | $33.72 | P/E | N/A | |||
| Day Low | $32.57 | EPS | $-1.02 | |||
| Volume | 274,771 | |||||
